VEGFA and neoplasm: Indeed, as we have recently reported, SLT-VEGF treatment of a syngeneic murine 4T1 tumor started as early as four days after implantation of 2,000 cells/mouse resulted in a distinct separation of treated mice into “responders” and “non-responders”.